healthcare News
Alumis shares jump 82% on Phase 3 success for psoriasis drug
Biotech plans FDA submission for ESK-001 in second half of 2026, marking first potential commercial product
Assembly Biosciences surges 13% as Gilead deal drives 153% revenue jump
Biotech firm narrows loss 84% to $0.55 per share; $35M option fee from Gilead strengthens cash position to $248.1M
SELLAS narrows losses as cash position strengthens to $114M
Biotech reports 50% reduction in FY2025 net loss while Phase 3 REGAL trial approaches final analysis with 72 of 80 events recorded
Inhibrx secures $75M loan as earnings miss weighs on shares
Biotech cuts R&D spending 45% and eyes Q2 BLA submission for ozekibart cancer treatment
FDA flags safety concern over Intuitive Surgical stapler
Regulator urges halt of devices linked to one death and four injuries, adding pressure to $171bn medtech giant
Taysha reports mixed earnings as gene therapy trials advance
Revenue beats expectations but EPS misses; $319.8M cash runway funds Rett syndrome program through 2028
Aveanna surges on 27% revenue growth, $175.5M acquisition
Adjusted EBITDA jumps 54% as home healthcare provider maintains upbeat 2026 outlook
4D Molecular Therapeutics misses earnings estimates
Gene therapy company reports $514M cash position, completes Phase 3 enrollment ahead of schedule